Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aprepitant 40mg/5ml oral suspension
0406000ADAAADAD
|
Aprepitant | Aprepitant | Central Nervous System | No data available |
|
Apresoline 20mg powder for solution for injection ampoules
0205010J0BBACAK
|
Apresoline | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Apretude 30mg tablets
0503010AWBCAAAA
|
Apretude | Cabotegravir | Infections | No data available |
|
Apretude 600mg/3ml prolonged-release inj vials
0503010AWBCABAB
|
Apretude | Cabotegravir | Infections | No data available |
|
Aprinox 5mg tablets
0202010B0BBABAC
|
Aprinox | Bendroflumethiazide | Cardiovascular System | No data available |
|
AproDerm barrier cream 3g sachets
23806558003
|
AproDerm barrier cream 3g sachets | Skin Fillers And Protectives | Stoma Appliances | No data available |
|
Aproten gluten free flour
090401070BNAAAI
|
Aproten (G/F Flour) | Gluten free/wheat free grains/flours | Nutrition and Blood | No data available |
|
Aproten low protein biscuits
0904010Z0BDAAAA
|
Aproten (Low protein biscuits) | Gluten free/low protein biscuits | Nutrition and Blood | No data available |
|
Aproten low protein crispbread
0904010Z0BDABAA
|
Aproten (Low protein biscuits) | Gluten free/low protein biscuits | Nutrition and Blood | No data available |
|
Aproten low protein pasta anellini
0904010T0BCAAAD
|
Aproten (Low protein pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Aproten low protein pasta ditalini
0904010T0BCACAD
|
Aproten (Low protein pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Aproten low protein pasta rigatini
0904010T0BCADAD
|
Aproten (Low protein pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Aproten low protein pasta spaghetti
0904010T0BCAEAD
|
Aproten (Low protein pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Aproten low protein pasta tagliatelle
0904010T0BCABAD
|
Aproten (Low protein pasta) | Gluten free/low protein pasta | Nutrition and Blood | No data available |
|
Aprotinin 1,000,000 Kallikrein inactivator units/100ml inf
0211000H0AAAFAF
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aprotinin 2,000,000 Kallikrein inactivator units/200ml inf
0211000H0AAAGAG
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aprotinin 500,000 Kallikrein inactivator units/50ml inf
0211000H0AAAEAE
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aptamil First milk liquid
0913501A0BCAAAC
|
Aptamil powder OTC infant formulae | Powder OTC infant formulae (0913501) | Nutrition and Blood | No data available |
|
Aptivus 100mg/ml oral solution
0503010ABBBABAB
|
Aptivus | Tipranavir | Infections | No data available |
|
Aptivus 250mg capsules
0503010ABBBAAAA
|
Aptivus | Tipranavir | Infections | No data available |
|
Apuro urostomy bag
23961069600
|
Apuro urostomy bag | Urostomy Bags | Stoma Appliances | No data available |
|
Apyrid 100mg/5ml oral solution
0906024N0CPAACX
|
Apyrid | Pyridoxine hydrochloride | Nutrition and Blood | No data available |
|
Aqua Ban gastro-resistant tablets
070403000BPBAAF
|
Proprietary compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Aqua Maris Baby nasal drops
21240000128
|
Aqua Maris Baby nasal drops | Nasal Products | Appliances | No data available |
|
Aqua-cool 0.5% cream
1303000AABDAAAA
|
Aqua-cool | Menthol | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.